The Japan autoinjector market was valued at USD 108.86 Million in 2025, driven by the expanding aging population and the growing shift towards home-based healthcare in the region. The market is anticipated to grow at a CAGR of 16.30% during the forecast period of 2026-2035, with the values likely to reach USD 492.79 Million by 2035. Japan's rapidly aging demographic increases the prevalence of chronic conditions like rheumatoid arthritis and diabetes, driving demand for autoinjectors. The well-established healthcare system of the country supports the adoption and integration of innovative medical devices, including autoinjectors.
Base Year
Historical Period
Forecast Period
Japan's aging population and advanced healthcare infrastructure are driving a shift toward home-based care and self-administration of medications, which is expected to fuel market demand in the coming years.
The rise in product approvals and commercial availability of innovative autoinjector devices is projected to elevate the Japan autoinjector market value in the forecast period.
The growing focus on the development of smarter and safer autoinjectors, including features like ergonomic designs, needle concealment, and smart connectivity for dose tracking, is a significant market trend.
Compound Annual Growth Rate
16.3%
Value in USD Million
2026-2035
*this image is indicative*
The market is witnessing significant growth, driven by the country’s expanding aging population, rising prevalence of chronic diseases, and increasing focus on self-administered treatments. Japan’s healthcare system, known for its technological advancement and patient-centric approach, is supporting the adoption of autoinjectors for biologic therapies, thereby boosting market demand. Moreover, companies such as Eisai Co., Ltd., SHL Medical Japan, Ypsomed Japan, and Terumo Corporation are actively contributing to the market growth through innovations in device design, ease of use, and collaborations with pharmaceutical firms.
Rising Prevalence of Chronic Diseases to Augment Market Demand
Rheumatoid arthritis affects an estimated 0.65% of the population in Japan , highlighting the country’s growing chronic disease burden. Additionally, Japan has an aging population of 36.25 million people aged 65 and older , making up nearly one-third of the total population, as reported by the Ministry of Internal Affairs and Communications. This combination of an aging population and rising rates of chronic illnesses is driving the demand for reliable drug delivery systems like autoinjectors, which is anticipated to bolster market growth.
The market is witnessing trends like new product launches and rapid technological innovations, boosting demand.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by Route of Administration
Market Breakup by Application
Market Breakup by End User
Segmentation Based on Application to Witness Substantial Growth
Based on the application, the market is segmented into rheumatoid arthritis, diabetes, multiple sclerosis, anaphylaxis, and others. Rheumatoid arthritis holds a substantial market share as it is one of the most prevalent chronic autoimmune diseases in Japan. The condition often requires long-term, consistent administration of biologics, many of which are delivered via autoinjectors for convenience and adherence. The elderly population, which is more prone to rheumatoid arthritis, further supports the growth of this segment.
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Nipro Corporation, headquartered in Osaka, is a leading Japanese manufacturer of medical devices, pharmaceuticals, and pharmaceutical packaging. The company has made significant strides in the development of advanced drug delivery devices. In the Japan autoinjector market, Nipro contributes by supplying components and integrated systems for prefilled syringes and autoinjectors, supporting both domestic and global pharmaceutical companies.
Terumo Corporation, based in Tokyo, is one of Japan’s most prominent medical technology companies. Its focus in the autoinjector market revolves around delivering high-precision injection systems, including prefillable syringes and custom autoinjector platforms. The company’s capabilities in device design, material science, and usability testing contribute to the development of autoinjectors that meet the needs of Japanese patients and regulatory standards.
Otsuka Pharmaceutical, a major Japanese healthcare company, focuses on pharmaceuticals, nutraceuticals, and medical devices. The company actively collaborates with global players like Pfizer to bring advanced therapies and delivery systems to Japan. Otsuka supports the localization, distribution, and adaptation of autoinjector-based therapies for chronic illnesses, particularly in the fields of psychiatry and oncology.
SHL Medical Japan K.K. is a key innovator and supplier in the Japan autoinjector market. Specializing in the design and manufacturing of advanced autoinjector systems, SHL Medical offers customizable and patient-friendly solutions for biologics and high-viscosity drugs. The company is known globally for its Molly® and Amber® autoinjector platforms, which are widely used in therapies for autoimmune diseases and other chronic conditions.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Ypsomed Japan, Mylan N.V., Pfizer, Eisai Co. Ltd., and Biogen Idec.
Upto 15% Off
USD
$1999 $1799
$3099 $2789
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Route of Administration |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share